Sponsored | News

Navigating Multiple Myeloma Treatment: What Patients Need To Know

December 3rd 2025

By Marlee Bogema, MSN, FNP-C, The Cancer and Hematology Centers

What You Should Know About Relapsed or Refractory Follicular Lymphoma

November 12th 2025

Sponsored advertising content is provided by Genmab A/S and AbbVie and does not necessarily reflect the views of CURE

Understanding TGCT and ROMVIMZA™ (vimseltinib)

August 20th 2025

Watch a webinar as experts on tenosynovial giant cell tumor (TGCT) share an overview of TGCT and a simple summary of the MOTION study.

From Overwhelmed to Empowered: Pluvicto is Changing Metastatic Prostate Cancer Care

July 30th 2025

Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like wandering through a foggy wilderness, quiet and cautious, afraid that any sound might reveal vulnerability. When forced to rethink the direction of life and navigate the various treatment options available while bearing the emotional toll of the unknown, it would be understandable to feel overwhelmed. Knowing there’s a clear next step can offer hope, a reason to speak up, and a renewed sense of control. For many, that step could be Pluvicto® (lutetium Lu 177 vipivotide tetraxetan).

Are You Worried About HER2+ Breast Cancer Recurrence?

April 4th 2025

The Importance of Spotting Endometrial Cancer

March 18th 2025

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

First relapse in multiple myeloma: the patient perspective

March 18th 2025

By Beth Faiman, PhD

Moving Beyond Chemotherapy: How Biomarker Testing is Changing Cancer Care

February 27th 2025

Meet Bladder Cancer Warrior Mike and His Wife and Care Partner, Heidi

February 26th 2025

Attitude of Gratitude: How one man’s positivity shaped his life after prostate cancer diagnosis

November 21st 2024